CD276 and ovarian cancer: CD276 Dash CAR-T also showed greater cytotoxicity in rechallenge of ovarian cancer cell SKOV3 at a lower 1:9 and 1:27 E: T ratios (Supplementary Fig. 3 and Supplementary Fig. 4b).